Nebenwirkungen · Inhixa
Inhixa 10,000 IU (100 mg)/1 mL solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 138–139
HOS-137086 · Präparat HOS-097950
138 Thrombocytopenia and thrombocytosis (see section 4.4 monitoring of platelet counts) System Prophylaxis in Prophylaxis Treatment in Extended Treatment in Treatment in organ surgical in medical patients with treatment of patients with patients with class patients patients DVT with or DVT and PE unstable acute STEMI without PE in patients angina and with active non-Q-wave cancer MI Blood Very common: Uncommon: Very common: Unknown: Uncommon: Common: and Thrombocyto Thrombo- Thrombocyto Thrombocyt Thrombo- Thrombocyto lympha sisβ cytopenia sisβ openia cytopenia sisβ tic Thrombo- system Common: Common: cytopenia disorde Thrombo- Thrombo- Very rare: rs cytopenia cytopenia Immuno- allergic thrombo- cytopenia β : Platelet increased >400 G/L
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-16T09:35:00Z · SHA-256 bbb8302fcca3a170cc14307df6fa307c1fd979d2c3ae4a14f42ba825950d23d7 · Passage 9947ac5f98da330cc4ab3746d273326a5e5bbcabab10813bba7995848b125d52 · Zeichen 7460–9169 im Abschnitt